Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis ; volume:10 ; number:1 ; day:13 ; month:7 ; year:2010 ; pages:1-9 ; date:12.2010
BMC infectious diseases ; 10, Heft 1 (13.7.2010), 1-9, 12.2010
- Creator
-
Soares-Weiser, Karla
- Contributor
-
Thomas, Sherine
G, Gail Thomson
Garner, Paul
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-10-207
- URN
-
urn:nbn:de:1111-2016030258084
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Soares-Weiser, Karla
- Thomas, Sherine
- G, Gail Thomson
- Garner, Paul
- SpringerLink (Online service)
Other Objects (12)
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus
Imported Crimean-Congo hemorrhagic fever cases in Istanbul
Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21